World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21671
World Ranking
15275
National Ranking
633

Paul Perrotte publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul Perrotte sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 463 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul Perrotte D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Perrotte sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul Perrotte is affiliated with the University of Montreal in Canada. Their research primarily focuses on the field of Medicine, with specialized work in Surgery, Pulmonary and Respiratory Medicine, Gender Studies, Radiology, Nuclear Medicine and Imaging, and Oncology.

Their recent publications cover various topics connected to urology and oncology, reflecting diverse interests and collaborations. Some of the notable recent papers include:

  • Survey of Canadian urology programs: Which aspects of the Canadian Residency Matching Service (CaRMS) application are the most important?, 2020, Canadian Urological Association Journal
  • Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma, 2020, Minerva Urologica e Nefrologica
  • Virtual "matchmaking" without visiting electives: Overview of the early U.S. experience and potential applications to the 2021 Canadian urology match, 2020, Canadian Urological Association Journal
  • A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer, 2022, Canadian Urological Association Journal
  • Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes, 2020, International Journal of Urology

Their frequent co-authors include:

  • Fred Saad (4 publications)
  • Pierre I. Karakiewicz (3 publications)
  • David-Dan Nguyen (3 publications)
  • Jason Y. Lee (3 publications)
  • Naeem Bhojani (3 publications)

Frequent venues for their work are:

  • Canadian Urological Association Journal (4 publications)
  • Minerva Urologica e Nefrologica (1 publication)
  • International Journal of Urology (1 publication)
  • Journal of the Endocrine Society (1 publication)
  • Radiotherapy and Oncology (1 publication)

Their research topics span several areas:

  • Diversity and Career in Medicine
  • Dental Education, Practice, Research
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Pancreatic and Hepatic Oncology Research

Paul Perrotte's body of work involves clinical and multidisciplinary approaches, reflecting engagement with complex cancer treatments and medical education topics. Their contributions include analysis of treatment modalities such as tumor ablation, partial nephrectomy, radiopharmaceutical therapies, and guideline adherence in urological cancers.

Best Publications

  • Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

    Paul Perrotte;Takashi Matsumoto;Keiji Inoue;Hiroki Kuniyasu

  • Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

    M. Bianchi;M. Sun;C. Jeldres;S. F. Shariat

  • Multi-institutional validation of a new renal cancer-specific survival nomogram.

    Pierre I. Karakiewicz;Alberto Briganti;Felix K H Chun;Quoc Dien Trinh

  • Distribution of metastatic sites in patients with prostate cancer: A population-based analysis

    Giorgio Gandaglia;Giorgio Gandaglia;Firas Abdollah;Firas Abdollah;Jonas Schiffmann;Vincent Trudeau

  • Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer

    Keiji Inoue;Joel W. Slaton;Beryl Y. Eve;Sun Jin Kim

  • Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule

    Joel W. Slaton;Paul Perrotte;Keiji Inoue;Colin P. N. Dinney

  • Radical versus partial nephrectomy: effect on overall and noncancer mortality.

    Laurent Zini;Paul Perrotte;Umberto Capitanio;Claudio Jeldres

  • Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

    Colin P. N. Dinney;Diane R. Bielenberg;Paul Perrotte;Reuven Reich

  • Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

    Keiji Inoue;Joel W. Slaton;Paul Perrotte;Darren W. Davis

  • Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis

    Maxine Sun;Rodolphe Thuret;Rodolphe Thuret;Firas Abdollah;Firas Abdollah;Giovanni Lughezzani;Giovanni Lughezzani

  • Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

    Naeem Bhojani;Claudio Jeldres;Jean Jacques Patard;Paul Perrotte

  • Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.

    Keiji Inoue;Joel W. Slaton;Sun Jin Kim;Paul Perrotte

  • Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis

    Firas Abdollah;Firas Abdollah;Giorgio Gandaglia;Giorgio Gandaglia;Rodolphe Thuret;Rodolphe Thuret;Jan Schmitges;Jan Schmitges

  • Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

    Joel W. Slaton;Keiji Inoue;Paul Perrotte;Adel K. El-Naggar

  • Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

    Pierre I. Karakiewicz;Shahrokh F. Shariat;Ganesh S. Palapattu;Amiel E. Gilad

  • A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer

    Jochen Walz;Andrea Gallina;Fred Saad;Francesco Montorsi

  • Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.

    Pierre I. Karakiewicz;Serge Benayoun;Michael W. Kattan;Paul Perrotte

  • Validation of a Nomogram for Prediction of Side Specific Extracapsular Extension at Radical Prostatectomy

    Thomas Steuber;Markus Graefen;Alexander Haese;Andreas Erbersdobler

  • The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation

    Giovanni Lughezzani;Maxine Sun;Paul Perrotte;Claudio Jeldres

  • A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.

    Firas Abdollah;Maxine Sun;Rodolphe Thuret;Rodolphe Thuret;Rodolphe Thuret;Claudio Jeldres

Frequent Co-Authors

Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Maxine Sun
Maxine Sun Harvard Medical School
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Markus Graefen
Markus Graefen Universität Hamburg
Quoc-Dien Trinh
Quoc-Dien Trinh Brigham and Women's Hospital
Fred Saad
Fred Saad University of Montreal
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Nazareno Suardi
Nazareno Suardi University of Genoa
Felix K.-H. Chun
Felix K.-H. Chun Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medical careers but prefer flexible study options, several online programs may suit your goals. Prospective nurse practitioners may find the easiest dnp program online to help advance your clinical expertise with minimal disruption to your career or family life.

For those looking to begin their healthcare journey quickly, consider lpn online programs that offer fast-track pathways to licensure. Mental health professionals aiming to specialize further might explore the shortest post master's pmhnp online programs for rapid entry into advanced psychiatric nursing roles.

Not all healthcare careers involve direct patient care. If you’re interested in leadership, business, or the management side of medicine, a health care administration online degree can provide the training you need for roles in hospitals, insurance companies, or other medical organizations.

Exploring these online options can help you find the right path, whether you’re seeking flexibility, speed, or affordability in your medical career journey.

Best Scientists Citing Paul Perrotte

Trending Scientists